Nova Eye Medical Income Statement

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Operating Revenue	29.27	23.33	17.03	13.38	13.39
Revenue	29.27	23.33	17.03	13.38	13.39
Revenue Growth (YoY)	25.47%	37.00%	27.26%	-0.12%	4.51%
Cost of Revenue	10.38	6.5	2.63	2.29	2.24
Gross Profit	18.89	16.83	14.39	11.09	11.15
Selling, General & Admin	19.63	16.8	21.87	17.4	13.21
Research & Development	3.24	3.97	-	-	-
Other Operating Expenses	5	5.03	2.01	1.58	1.39
Operating Expenses	27.87	25.8	26.17	20.79	16.12
Operating Income	-8.99	-8.97	-11.78	-9.7	-4.97
Interest Expense	-0.16	-0.07	-0.05	-0.06	-0.07
Interest & Investment Income	0.08	0.12	0.1	0.03	0.24
Currency Exchange Gain (Loss)	-	-	0.14	-0.05	-0.48
Other Non Operating Income (Expenses)	-	0.13	0.63	0.54	0.03
EBT Excluding Unusual Items	-9.06	-8.79	-10.96	-9.24	-5.25
Asset Writedown	-	-	-6.04	-	-
Other Unusual Items	-	-	-	1.42	-
Pretax Income	-9.06	-8.79	-17	-7.82	-5.25
Income Tax Expense	-	-	-1.71	-0.32	-0.89
Earnings From Continuing Operations	-9.06	-8.79	-15.29	-7.5	-4.36
Net Income	-9.06	-8.79	-15.29	-7.5	-4.36
Net Income to Common	-9.06	-8.79	-15.29	-7.5	-4.36
Shares Outstanding (Basic)	247	204	156	145	144
Shares Outstanding (Diluted)	247	204	156	145	144
Shares Change (YoY)	21.16%	30.89%	7.83%	0.69%	0.03%
EPS (Basic)	-0.04	-0.04	-0.10	-0.05	-0.03
EPS (Diluted)	-0.04	-0.04	-0.10	-0.05	-0.03
Free Cash Flow	-6.45	-8.07	-7.09	-4.85	-13.53
Free Cash Flow Per Share	-0.03	-0.04	-0.04	-0.03	-0.09
Gross Margin	64.54%	72.15%	84.55%	82.89%	83.25%
Operating Margin	-30.70%	-38.47%	-69.19%	-72.50%	-37.07%
Profit Margin	-30.95%	-37.69%	-89.83%	-56.03%	-32.52%
Free Cash Flow Margin	-22.03%	-34.59%	-41.63%	-36.27%	-100.99%
EBITDA	-6.72	-5.98	-9.48	-7.89	-3.45
EBITDA Margin	-22.97%	-25.66%	-55.69%	-58.96%	-25.76%
D&A For EBITDA	2.26	2.99	2.3	1.81	1.52
EBIT	-8.99	-8.97	-11.78	-9.7	-4.97
EBIT Margin	-30.70%	-38.47%	-69.19%	-72.50%	-37.07%
Advertising Expenses	-	-	3.2	1.78	0.73

Source: S&P Global Market Intelligence. Standard template. Financial Sources.